Allucent (Cary) Overview
- Year Founded
-
1988
- Status
-
Private
- Employees
-
1,460
- Latest Deal Type
-
Debt - Acquisition
- Financing Rounds
-
3
- Investments
-
4
Allucent (Cary) General Information
Description
Operator of an international regulatory and clinical contract research organization intended to help sponsors to accelerate the delivery of novel treatments to the patients who need them. The company offers a range of services including regulatory strategy and submissions, project management, medical writing, biostatistics, data management and trial management of preclinical and clinical studies required for marketing approval for clients in the pharmaceutical, biotechnology and medical device industries.
Contact Information
Website
www.allucent.comCorporate Office
- 2000 Centregreen Way
- Suite 300
- Cary, NC 27513
- United States
Corporate Office
- 2000 Centregreen Way
- Suite 300
- Cary, NC 27513
- United States
Allucent (Cary) Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Allucent (Cary) Comparisons
Industry
Financing
Details
Allucent (Cary) Competitors (35)
One of Allucent (Cary)’s 35 competitors is Everest Clinical Research, a Private Equity-Backed company based in Markham, Canada.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Everest Clinical Research | Private Equity-Backed | Markham, Canada | ||||
North American Science Associates | Private Equity-Backed | Toledo, OH | ||||
Celerion | Private Equity-Backed | Lincoln, NE | ||||
Atlant Clinical | Corporate Backed or Acquired | Moscow, Russia | ||||
Aragen Life Sciences | Private Equity-Backed | Hyderabad, India |
Allucent (Cary) Signals
Allucent (Cary) Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Allucent (Cary) Investments & Acquisitions (4)
Allucent (Cary)’s most recent deal was a Buyout/LBO with Pharm-Olam. The deal was made on 05-Jan-2022.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Pharm-Olam | 05-Jan-2022 | Buyout/LBO | Other Healthcare Services | ||
Nuventra Pharma Sciences | 26-May-2021 | Buyout/LBO | Consulting Services (B2B) | ||
Array Biostatistics | 15-Sep-2020 | Merger/Acquisition | Other Healthcare Services | ||
SMS-oncology | 28-Oct-2019 | Buyout/LBO | Other Pharmaceuticals and Biotechnology |
Affiliates
Subsidiaries (2)
Name | Industry | Location | Year Founded |
---|---|---|---|
SMS-oncology | Schiphol, Netherlands | 2007 | |
Cato BioVentures | Durham, NC | 1990 |
Allucent (Cary) FAQs
-
When was Allucent (Cary) founded?
Allucent (Cary) was founded in 1988.
-
Where is Allucent (Cary) headquartered?
Allucent (Cary) is headquartered in Cary, NC.
-
What is the size of Allucent (Cary)?
Allucent (Cary) has 1,460 total employees.
-
What industry is Allucent (Cary) in?
Allucent (Cary)’s primary industry is BPO/Outsource Services.
-
Is Allucent (Cary) a private or public company?
Allucent (Cary) is a Private company.
-
What is Allucent (Cary)’s current revenue?
The current revenue for Allucent (Cary) is
. -
Who are Allucent (Cary)’s investors?
JLL Partners and Water Street Healthcare Partners have invested in Allucent (Cary).
-
Who are Allucent (Cary)’s competitors?
Everest Clinical Research, North American Science Associates, Celerion, Atlant Clinical, and Aragen Life Sciences are some of the 35 competitors of Allucent (Cary).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »